Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CTMX stock: CytomX Therapeutics Inc

Current Rating
Strong Sell

Previous Rating:

Strong Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$11.50
Market Cap
400.1M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
4.46
P/S
37.1
Dividend %
-
P/CF
14.4
P/FCF
-
Op. Cash Flow
-12.1K
FCF
-0.4
Op. Margin
-528.30%
Net Margin
-529.00%
ROE
-53.00%
ROI
-26.30%
ROA
-28.90%
EPS Growth
11.60%
Current Ratio
12.1
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Oramed Pharmaceuticals, Inc. (ORMP) $6.22 - - 81.2M Strong Buy
Reliv International, Inc (RELV) $4.32 - - 8.6M Strong Buy
CRYO-CELL International, Inc. (CCEL) $4.85 - - 31M Strong Buy
CYANOTECH CORP (CYAN) $4.50 - - 24.4M Strong Buy
Daxor Corporation (DXR) $8.59 - 0.40% 31.5M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More